• English
  • Korean
  • Chinese
表紙
市場調査レポート - 244191

止血:世界の治験レビュー

Hemostasis Global Clinical Trials Review, H2, 2013

発行 GlobalData
出版日 ページ情報 英文 89 Pages
電子版即納可
価格
止血:世界の治験レビュー Hemostasis Global Clinical Trials Review, H2, 2013
出版日: 2013年12月30日 ページ情報: 英文 89 Pages
概要

当レポートでは、世界の止血薬の臨床試験について調査し、 地域別の臨床試験数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、 中断(一時中止、廃止、打ち切り)された試験のリストなどを提供しており、 概略以下の構成でお届けします。

目次

  • イントロダクション
    • 止血
    • レポートガイダンス
  • 臨床試験: 地域別
  • 臨床試験: 国別
    • 臨床試験に寄与している主要5ヵ国 − アジア太平洋地域
    • 臨床試験に寄与している主要5ヵ国 − 欧州
    • 臨床試験に寄与している主要国 − 北米
    • 臨床試験に寄与している主要国 − 中東およびアフリカ
  • 臨床試験 BRIC 諸国
  • 臨床試験 G7 諸国
  • 臨床試験 G7 諸国 , 治験ステータス別
  • 臨床試験 E7 諸国
  • 臨床試験 E7 諸国 , 治験ステータス別
  • 相別臨床試験
    • 進行中の治験:相別
  • 臨床試験: 治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 参加主要企業
  • 有望な 治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要: 主要企業
      • Novo Nordisk A/S
      • Baxter Healthcare Corporation
      • ZymoGenetics, Inc.
      • Ethicon Endo-Surgery, Inc.
      • Teva's Women's Health
      • Braun Aesculap
      • Ethicon Endo-Surgery, Inc.
      • Profibrix, BV.
      • Cardiochirurgia E.H.
      • Nycomed GmbH
      • Kantonsspital Aarau AG
      • Aesculap AG
      • Esbjerg Dentallaboratorium Aps
      • Nycomed International Management GmbH
      • Grifols, S.A.
      • Vascular Solutions, Inc.
      • Johnson & Johnson
      • Baxter International Inc.
      • Bristol-Myers Squibb Company
    • 臨床試験概要: トップレベルの大学 / 研究機関 / 病院
      • Cardiovascular Institute & Fuwai Hospital
      • Rafsanjan University of Medical Sciences
      • Karolinska Institutet
      • The University of Hong Kong
      • University of Illinois
      • Radboud University
  • 5大臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Hemostasis Global Clinical Trials Review, H2, 2013" provides data on the Hemostasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemostasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemostasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Introduction 6
  • Hemostasis 6
  • Report Guidance 6
  • Clinical Trials by Region 7
  • Clinical Trials by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by BRIC Nations 15
  • Clinical Trials by G7 Nations 16
  • Clinical Trials in G7 Nations by Trial Status 17
  • Clinical Trials by E7 Nations 18
  • Clinical Trials in E7 Nations by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Unaccomplished Trials of Hemostasis 23
  • Subjects Recruited Over a Period of Time 25
  • Prominent Sponsors 26
  • Top Companies Participating in Hemostasis Therapeutics Clinical Trials 27
  • Prominent Drug Comparison 28
  • Clinical Trial Profiles 29
  • Clinical Trial Overview of Top Companies 29
  • Baxter International Inc. 29
  • Clinical Trial Overview of Baxter International Inc. 29
  • Johnson & Johnson 30
  • Clinical Trial Overview of Johnson & Johnson 30
  • Novo A/S 31
  • Clinical Trial Overview of Novo A/S 31
  • ZymoGenetics, Inc. (Inactive) 32
  • Clinical Trial Overview of ZymoGenetics, Inc. (Inactive) 32
  • Takeda Pharmaceutical Company Limited 33
  • Clinical Trial Overview of Takeda Pharmaceutical Company Limited 33
  • Teva Women's Health 34
  • Clinical Trial Overview of Teva Women's Health 34
  • ProFibrix, BV. 35
  • Clinical Trial Overview of ProFibrix, BV. 35
  • Grifols, S.A. 36
  • Clinical Trial Overview of Grifols, S.A. 36
  • Ethicon, Inc. 37
  • Clinical Trial Overview of Ethicon, Inc. 37
  • B. Braun Melsungen AG 38
  • Clinical Trial Overview of B. Braun Melsungen AG 38
  • Clinical Trial Overview of Top Institutes / Government 39
  • National Heart, Lung, and Blood Institute 39
  • Clinical Trial Overview of National Heart, Lung, and Blood Institute 39
  • National Taiwan University Hospital 40
  • Clinical Trial Overview of National Taiwan University Hospital 40
  • Cardiovascular Institute & Fuwai Hospital 41
  • Clinical Trial Overview of Cardiovascular Institute & Fuwai Hospital 41
  • University of Manitoba 42
  • Clinical Trial Overview of University of Manitoba 42
  • Medical University of Silesia 43
  • Clinical Trial Overview of Medical University of Silesia 43
  • Esbjerg Dentallaboratorium Aps 44
  • Clinical Trial Overview of Esbjerg Dentallaboratorium Aps 44
  • Karolinska Institutet 45
  • Clinical Trial Overview of Karolinska Institutet 45
  • The University of Hong Kong 46
  • Clinical Trial Overview of The University of Hong Kong 46
  • Chinese University of Hong Kong 47
  • Clinical Trial Overview of Chinese University of Hong Kong 47
  • University Hospital Basel 48
  • Clinical Trial Overview of University Hospital Basel 48
  • Five Key Clinical Profiles 49

Appendix 86

  • Abbreviations 86
  • Definitions 86
  • Research Methodology 87
  • Secondary Research 87
  • About GlobalData 88
  • Contact Us 88
  • Disclaimer 88
  • Source 89

List of Tables

  • Hemostasis Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
  • Hemostasis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
  • Hemostasis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
  • Hemostasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
  • Hemostasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
  • Hemostasis Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
  • Hemostasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13
  • Hemostasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 14
  • Hemostasis Therapeutics Clinical Trials, BRIC Countries, 2013* 15
  • Hemostasis Therapeutics Clinical Trials, G7 Countries, 2013* 16
  • Hemostasis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
  • Hemostasis Therapeutics Clinical Trials, E7 Countries, 2013* 18
  • Hemostasis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
  • Hemostasis Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
  • Hemostasis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21
  • Hemostasis Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
  • Hemostasis Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 23
  • Hemostasis Therapeutics Market, Global, Terminated Clinical Trials, 2013* 24
  • Hemostasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 25
  • Hemostasis Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 26
  • Hemostasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 27
  • Hemostasis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 28
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2013* 29
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 30
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2013* 31
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by ZymoGenetics, Inc. (Inactive), 2013* 32
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2013* 33
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Women's Health, 2013* 34
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by ProFibrix, BV., 2013* 35
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2013* 36
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ethicon, Inc., 2013* 37
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by B. Braun Melsungen AG, 2013* 38
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 39
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 40
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiovascular Institute & Fuwai Hospital, 2013* 41
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2013* 42
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Silesia, 2013* 43
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Esbjerg Dentallaboratorium Aps, 2013* 44
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institutet, 2013* 45
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2013* 46
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2013* 47
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2013* 48

List of Figures

  • Hemostasis Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
  • Hemostasis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
  • Hemostasis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
  • Hemostasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
  • Hemostasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
  • Hemostasis Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
  • Hemostasis Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
  • Hemostasis Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
  • Hemostasis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
  • Hemostasis Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
  • Hemostasis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
  • Hemostasis Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
  • Hemostasis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
  • Hemostasis Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
  • Hemostasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 25
  • Hemostasis Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 26
  • Hemostasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 27
  • Hemostasis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 28
  • GlobalData Methodology 87
Back to Top